Cell

Medgenics gets (bio)pumping

Medgenics gets (bio)pumping

By Katrina Megget

Medgenics' Biopump could be the solution to the issues surrounding
protein therapy and is set to take on the $51bn US
biopharmaceutical market after raising £3.28m ($6.76m) in funding
in its Initial Public Offering.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers